Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.510
+0.100 (7.09%)
At close: Apr 17, 2026, 4:00 PM EDT
1.491
-0.019 (-1.28%)
After-hours: Apr 17, 2026, 7:43 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $168.57 million as of April 17, 2026. Its market cap has increased by 119.60% in one year.
Market Cap
168.57M
Enterprise Value
153.00M
1-Year Change
119.60%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $168.57M, an increase of 141.62%. That is a compound annual growth rate of 12.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 168.57M | 77.30% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 332.43M |
| Organogenesis Holdings | 328.03M |
| Evolus | 294.72M |
| Organigram Global | 211.17M |
| Anika Therapeutics | 206.24M |
| Aurora Cannabis | 205.54M |
| Lifecore Biomedical | 194.88M |
| Alpha Teknova | 143.61M |